Production of high-complexity frameshift neoantigen peptide microarrays

Luhui Shen1, Zhan-Gong Zhao1, John C Lainson1

  • 1Center for Innovations in Medicine, Biodesign Institute, Arizona State University Tempe AZ USA chris.diehnelt@asu.edu stephen.johnston@asu.edu.

RSC Advances
|May 6, 2022
PubMed
Summary

This study presents a novel peptide microarray capable of synthesizing over 300 million frameshift neoantigens. This technology enables efficient profiling of patient-specific antibodies against these neoantigens in a single assay.